Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
01/2006
01/03/2006CA2132297C Pyrido[2,3-d]pyrimidine derivatives as phosphodiesterase inhibitors
12/2005
12/29/2005WO2005123735A1 Process for producing evodiamine-containing composition
12/29/2005WO2005123734A1 Pyrimidine derivatives antagonists of vitronectin receptor
12/29/2005WO2005123733A1 Pyridopyrazines for combatting phytopathogenic fungi
12/29/2005WO2005123732A1 1-aza-bicyclo[3.3.1]nonanes
12/29/2005WO2005123731A2 Pyrrolopyridine derivatives and their use as crth2 antagonists
12/29/2005WO2005123730A1 Amino-halogen-imidazopyridines as proton pump inhibitors
12/29/2005WO2005123729A1 Lewis acid mediated synthesis of cyclic esters
12/29/2005WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides
12/29/2005WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
12/29/2005WO2005123698A1 Fungicides based on nitrogen-containing heterocycles
12/29/2005WO2005123693A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005WO2005123685A1 Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatement of diabetes
12/29/2005WO2005123672A2 Kinase inhibitors
12/29/2005WO2005123634A1 Fluorene derivative and organic electroluminescent device using same
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005WO2005076783A3 Sulfone substituted imidazo ring ethers
12/29/2005US20050288502 Substituted heterocyclic compounds and methods of use
12/29/2005US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors
12/29/2005US20050288354 peroxisome proliferator activated receptor scaffold and modulator; 3-[1-(4-butoxy-benzenesulfonyl)-5-metoxy-1H-indol-3-yl]-propionic acid methyl etster; for identification or development of additional active compound; bioassay: binding affinity or specificity; antidiabetic, obesity, metabolic disorder
12/29/2005US20050288334 preparing an optically pure proton pump inhibitor having a sulfinyl structure using a chiral zirconium complex or a chiral hafnium complex; comprising oxidizing a corresponding sulfide
12/29/2005US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine
12/29/2005US20050288322 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/29/2005US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition
12/29/2005US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates
12/29/2005US20050288318 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
12/29/2005US20050288316 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists
12/29/2005US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine
12/29/2005US20050288311 2-(dipropylamino)-8-(4-thiomorpholinyl)pyrido[3,4-d]pyrimidin-4(3H)-one; kianses inhibitor; anticarcinlgenic, antidiabetic, antiinflammatory, hypotensive agent; nontoxic
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288299 Preferably p38-alpha; azaindoles, azabenzofurans, or azabenzothiophenes are coupled through a piperidine or piperazine type linker to another cyclic moiety; antiarthritic, anticarcinogenic, antiinflammatory agents; analgesics
12/29/2005US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
12/29/2005US20050288290 e.g. 1-(4-(6-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(2-(4-fluorophenyl)acetyl)thiourea; mitogen-activated protein kinase inhibitor; anticarcinogenic agent, angiogenesis inhibitor; solid tumor, leukemia
12/29/2005US20050288273 Antibacterial agents
12/29/2005US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
12/29/2005CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2569913A1 Amino-halogen-imidazopyridines as proton pump inhibitors
12/29/2005CA2569125A1 Pyrrolopyridine derivatives and their use as crth2 antagonists
12/29/2005CA2566155A1 1-aza-bicyclo[3.3.1]nonanes
12/29/2005CA2565966A1 Lewis acid mediated synthesis of cyclic esters
12/28/2005EP1609792A1 A process for the preparation of imiquimod and intermediates thereof
12/28/2005EP1609791A1 Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-Chloro-2-thienyl)methy]propy]amino]-3H-imidazo[4,5-b]pyridin-3-y]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1608649A2 Method for the enantioselective preparation of sulphoxide derivatives
12/28/2005EP1608648A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta
12/28/2005EP1608627A2 Bicyclic anilide spirohydantoin cgrp receptor antagonists
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1389208B1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/28/2005EP1385512B1 Use of pyridoindolone derivatives for preparing anticancer medicines
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1257276B1 Antiviral azaindole derivatives
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1140930B1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714082A Process for preparation of imidazolyl compounds
12/28/2005CN1714060A Method for deuteration or tritiation of heterocyclic ring
12/28/2005CN1714044A Synthesis of ITQ-17 in the absence of fluoride ions
12/28/2005CN1713910A Azaindole derivatives as inhibitors of p38 kinase
12/28/2005CN1233643C Ramification of a compound of medication as well as preparation method and application
12/28/2005CN1233642C Novel anticancer plants extract and process of extraction thereof
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/27/2005US6979696 Method for detecting a gram-negative bacterial autoinducer molecule
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979566 Method of treatment of viral infection including HIV using water soluble fullerenes—III
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/24/2005CA2510576A1 A process for the preparation of imiquimod
12/22/2005WO2005121274A1 Red electroluminescent compounds and organic electroluminescent device using the same
12/22/2005WO2005121159A1 Novel dna threading intercalators
12/22/2005WO2005121152A1 Substituted triazole derivatives as oxytocin antagonists
12/22/2005WO2005121143A1 Flavopereirine derivatives for cancer therapy
12/22/2005WO2005121142A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido’2,3-d! pyrimidine derivatives and related compounds for the treatment of cancer
12/22/2005WO2005121141A1 Pyrrolopyridine derivatives and use thereof for treating diseases mediated by prostaglandin d2 (pgd2)
12/22/2005WO2005121140A1 Pyrrolopyridine derivatives
12/22/2005WO2005121139A1 Substituted tricyclic benzimidazoles
12/22/2005WO2005121138A2 Heterotricyclic compounds for use as hcv inhibitors
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/22/2005WO2005120505A2 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005100340A3 Polycyclic pyridines as potassium ion channel modulators
12/22/2005US20050283006 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282854 Amide substituted imidazopyridines
12/22/2005US20050282853 microbial infections from a protozoan pathogen, such as Trypanosoma brucei rhodesiense and Plasmodium falciparum; 2,6-Bis[4-(N-hydroxyamidino-phenyl)]-imidazo[1,2-a]pyridine; reacting an aryl-substituted alkylketone halide with an aminopyridine; adding a cyanophenyl-boronic acid
12/22/2005US20050282850 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid
12/22/2005US20050282848 Synthesis and use of tetracyclic benzamide derivatives; antidiabetic agents; coupling isochromene anhydride with cyanobenzene compound and performing ring substitution reactions
12/22/2005US20050282842 Therapeutic compounds based on pyrazolopyridine derivatives
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282813 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
12/22/2005US20050282811 Diazabicyclic histamine-3 receptor antagonists
1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 646